Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs GENNEX LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA GENNEX LAB. SANDU PHARMA/
GENNEX LAB.
 
P/E (TTM) x 48.5 35.6 136.1% View Chart
P/BV x 1.4 4.6 30.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANDU PHARMA   GENNEX LAB.
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
GENNEX LAB.
Mar-23
SANDU PHARMA/
GENNEX LAB.
5-Yr Chart
Click to enlarge
High Rs869 945.1%   
Low Rs505 1,044.7%   
Sales per share (Unadj.) Rs67.63.4 2,013.4%  
Earnings per share (Unadj.) Rs1.60.3 565.2%  
Cash flow per share (Unadj.) Rs2.10.3 637.8%  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.64.5 893.0%  
Shares outstanding (eoy) m9.66176.64 5.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.02.1 48.7%   
Avg P/E ratio x43.325.0 173.4%  
P/CF ratio (eoy) x32.321.0 153.6%  
Price / Book Value ratio x1.71.5 109.7%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m6581,229 53.6%   
No. of employees `000NANA-   
Total wages/salary Rs m11179 140.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m653593 110.1%  
Other income Rs m340 8.3%   
Total revenues Rs m657633 103.7%   
Gross profit Rs m2547 53.0%  
Depreciation Rs m59 56.3%   
Interest Rs m114 5.9%   
Profit before tax Rs m2264 34.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m715 47.9%   
Profit after tax Rs m1549 30.9%  
Gross profit margin %3.87.9 48.1%  
Effective tax rate %31.422.8 137.8%   
Net profit margin %2.38.3 28.1%  
BALANCE SHEET DATA
Current assets Rs m255487 52.5%   
Current liabilities Rs m139295 47.0%   
Net working cap to sales %17.832.3 55.2%  
Current ratio x1.81.6 111.5%  
Inventory Days Days654 1,600.5%  
Debtors Days Days26857,912,589 0.0%  
Net fixed assets Rs m286835 34.3%   
Share capital Rs m97180 53.6%   
"Free" reserves Rs m296623 47.5%   
Net worth Rs m392804 48.8%   
Long term debt Rs m0163 0.0%   
Total assets Rs m5421,322 41.0%  
Interest coverage x28.75.7 502.9%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.20.4 268.7%   
Return on assets %3.04.7 62.2%  
Return on equity %3.96.1 63.3%  
Return on capital %5.98.0 73.2%  
Exports to sales %042.1 0.0%   
Imports to sales %013.6 0.0%   
Exports (fob) Rs mNA250 0.0%   
Imports (cif) Rs mNA81 0.0%   
Fx inflow Rs m0250 0.0%   
Fx outflow Rs m086 0.0%   
Net fx Rs m0164 0.0%   
CASH FLOW
From Operations Rs m2237 0.9%  
From Investments Rs m5-383 -1.4%  
From Financial Activity Rs m6210 2.8%  
Net Cashflow Rs m1364 21.0%  

Share Holding

Indian Promoters % 42.9 23.6 181.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 76.4 74.7%  
Shareholders   10,021 69,723 14.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs GENNEX LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs GENNEX LABORATORIES Share Price Performance

Period SANDU PHARMA GENNEX LABORATORIES S&P BSE HEALTHCARE
1-Day -1.13% 3.27% 1.18%
1-Month -15.66% -12.26% -0.75%
1-Year 8.99% 195.41% 61.82%
3-Year CAGR 19.03% 63.80% 18.16%
5-Year CAGR 20.97% 40.61% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the GENNEX LABORATORIES share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of GENNEX LABORATORIES the stake stands at 23.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of GENNEX LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

GENNEX LABORATORIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of GENNEX LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.